0000000000805186

AUTHOR

Manuel Belda ÁLvarez

showing 3 related works from this author

Análisis de resultados del Programa de Control de Calidad Externo SEIMC. Año 2018

2020

This article provides an analysis of the results obtained in 2018 by the participants inscribed in the External Quality Control Programme of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), which includes controls for bacteriology, serology, mycology, parasitology, mycobacteria, virology, molecular microbiology, and genotypic bacterial resistance. The results obtained in 2018 confirm the excellent skill and good technical standards found in the vast majority of Spanish clinical microbiology laboratories, as shown in previous editions. However, the programme again shows that erroneous results can be obtained in any laboratory and even in clinically relevant deter…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtybusiness.industryeducation030106 microbiology03 medical and health sciencesClinical microbiology0302 clinical medicineMolecular microbiologymedicineMedical physics030212 general & internal medicinebusinessEnfermedades Infecciosas y Microbiología Clínica
researchProduct

Análisis de resultados del Programa de Control de Calidad Externo SEIMC de carga viral del VIH-1, VHC y VHB. AÑO 2018

2020

BACKGROUND Human immunodeficiency virus type 1 (HIV-1) and hepatitis B (HBV) and C virus (HCV) viral load determinations are among the most relevant markers for the follow-up of patients infected with these viruses. External quality control tools are crucial to ensure the accuracy of the results obtained by microbiology laboratories. This article summarised the results obtained from the 2017 SEIMC External Quality Control Programme for HIV-1, HCV, and HBV viral loads and HCV genotyping. METHODS AND RESULTS In the HIV-1 programme, a total of five standards were sent. One standard consisted of seronegative human plasma, while the remaining four contained plasma from three different viremic pa…

Microbiology (medical)medicine.medical_specialtyHCV Genotypingbusiness.industryHuman immunodeficiency virus (HIV)virus diseasesQuality controlRepeatabilityHepatitis Bmedicine.diseasemedicine.disease_causeVirusHuman plasmaInternal medicineMedicinebusinessViral loadEnfermedades Infecciosas y Microbiología Clínica
researchProduct

Candida auris: descripción de un brote

2020

Resumen Candida auris es una levadura multirresistente emergente que causa infecciones invasivas graves y brotes con una alta mortalidad. El control de C . auris es un reto. Laboratorios, clinicos e instituciones sanitarias deben trabajar conjuntamente para mejorar la identificacion y el tratamiento de la infeccion, asi como el control de la transmision. Esta revision describe los aspectos generales de la biologia, diagnostico y tratamiento de C. auris, al igual que las recomendaciones publicadas recientemente por un grupo de expertos. Tambien se presenta la experiencia de un brote de C. auris en el Consorcio Hospital General Universitario de Valencia desde septiembre de 2017 hasta agosto d…

0301 basic medicineMicrobiology (medical)03 medical and health sciences0302 clinical medicine030106 microbiology030212 general & internal medicineEnfermedades Infecciosas y Microbiología Clínica
researchProduct